# Kwabena (NMI) Ayesu, M.D. – FDA Inspection, Jul 31, 2019

Source: https://www.keypedia.com/records/fda_inspections/kwabena-nmi-ayesu-md/e974a181-ac87-43ab-a538-dfe76fa288e7
Source feed: FDA_Inspections

> FDA inspection 1099885 of Kwabena (NMI) Ayesu, M.D., July 31, 2019. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1099885
- Company Name: Kwabena (NMI) Ayesu, M.D.
- Inspection Date: 2019-07-31
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1195661 - 2023-01-27](https://www.keypedia.com/records/fda_inspections/kwabena-nmi-ayesu-md/0ee2832f-03d0-4794-9d18-f1b97b7d0537)
- FDA Inspection 1139836 - 2021-04-02

## Related Officers

- [Company Rep](https://www.keypedia.com/people/ladislav-kermet/b84bf1f8-d79b-40c7-9c18-c7a8f8f13c45)

Company: https://www.keypedia.com/companies/kwabena-nmi-ayesu-md/9e5eea3e-0997-4f23-a9f3-935bec5b4c97

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
